146 related articles for article (PubMed ID: 3712391)
21. Acetylator polymorphism in Alzheimer's disease.
Ladero JM; Barquero MS; Coria F; Molina JA; Jiménez-Jiménez FJ; Benítez J
Eur J Med; 1993 May; 2(5):281-3. PubMed ID: 8252158
[TBL] [Abstract][Full Text] [Related]
22. Sparteine oxidation polymorphism in Greenlanders living in Denmark.
Brøsen K
Br J Clin Pharmacol; 1986 Oct; 22(4):415-9. PubMed ID: 3768256
[TBL] [Abstract][Full Text] [Related]
23. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
Hall S
Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
[TBL] [Abstract][Full Text] [Related]
25. Acetylator polymorphism in Parkinson's disease.
Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
[TBL] [Abstract][Full Text] [Related]
26. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
27. Sparteine oxidation polymorphism: a family study.
Brøsen K; Otton SV; Gram LF
Br J Clin Pharmacol; 1986 Jun; 21(6):661-7. PubMed ID: 3741716
[TBL] [Abstract][Full Text] [Related]
28. The association of the slow acetylator phenotype with bladder cancer.
Evans DA; Eze LC; Whibley EJ
J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
[TBL] [Abstract][Full Text] [Related]
29. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
30. Ageing and acetylator phenotype as determined by administration of sulphadimidine.
Pontiroli AE; De Pasqua A; Bonisolli L; Pozza G
Eur J Clin Pharmacol; 1985; 28(4):485-6. PubMed ID: 4029255
[No Abstract] [Full Text] [Related]
31. Determination of the acetylator phenotype in a Northern Nigerian population.
Fawcett IW; Gammon PT
Tubercle; 1975 Sep; 56(3):199-201. PubMed ID: 1216338
[TBL] [Abstract][Full Text] [Related]
32. Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.
Broly F; Gaedigk A; Heim M; Eichelbaum M; Morike K; Meyer UA
DNA Cell Biol; 1991 Oct; 10(8):545-58. PubMed ID: 1681816
[TBL] [Abstract][Full Text] [Related]
33. Acetylation of sulfamethazine in a Nigerian population.
Eze LC; Obidoa O
Biochem Genet; 1978 Dec; 16(11-12):1073-7. PubMed ID: 751642
[TBL] [Abstract][Full Text] [Related]
34. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
Chapron DJ; Kramer PA; Mercik SA
Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
[TBL] [Abstract][Full Text] [Related]
35. [Genetic polymorphism of acetylation and hydroxylation in the Briton population].
Bressollette L; Berthou F; Riche C; Mottier D; Floch HH
Therapie; 1990; 45(2):99-103. PubMed ID: 2353336
[TBL] [Abstract][Full Text] [Related]
36. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
Reeves PT; Kinnear BF; Minchin RF; Ilett KF
Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
[TBL] [Abstract][Full Text] [Related]
37. No effect of smoking on sulfamethazine acetylation.
Miller ME; Cosgriff JM
Drug Intell Clin Pharm; 1984; 18(7-8):620-2. PubMed ID: 6745090
[TBL] [Abstract][Full Text] [Related]
38. Polymorphically acetylated aminoglutethimide in humans.
Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
[TBL] [Abstract][Full Text] [Related]
39. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
40. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
